| Symbol | MEOBF |
|---|---|
| Name | MESOBLAST LTD. |
| Sector | HEALTH CARE |
| Region | Oceania |
| Industry | - |
| Address | 3000 Australia VA Level 38, 55 Collins St. |
| Telephone | 613 9639 6036 |
| Fax | — |
| — | |
| Website | https://www.mesoblast.com/ |
| Incorporation | AU |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001345099 |
| Description | Mesoblast is developing a series of high margin, off-the-shelf adult stem cell products that are obtained from a single donor, commercially expanded and frozen, and subsequently used in potentially thousands of unrelated, or allogeneic, recipients at the time and place of need. Additional info from OTC: Additional info from NASDAQ: |
2026-01-14 15:57
New Form 424B3 - MESOBLAST LTD Filed: 2026-01-14 AccNo: 0001213900-26-004248 Size: 327 KB
Read more
2025-12-31 11:29
New Form F-3ASR - MESOBLAST LTD Filed: 2025-12-31 AccNo: 0001213900-25-126785 Size: 539 KB
Read more
2025-12-30 21:20
New Form F-3 - MESOBLAST LTD Filed: 2025-12-30 AccNo: 0001213900-25-126633 Size: 558 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT04366830 | Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC… | — | Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19 | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT01510431 | Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous In… | — | Crohn's Disease | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT00759018 | Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Ster… | — | Graft vs Host Disease | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT04456439 | Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC… | — | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT07568535 | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of … | Phase3 | GVHD - Graft-Versus-Host Disease | Not_Yet_Recruiting | 2026-08-31 | 2028-07-01 | ClinicalTrials.gov |
| NCT06325566 | Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With … | Phase3 | Degenerative Disc Disease | Recruiting | 2024-07-03 | 2027-10-01 | ClinicalTrials.gov |
| NCT04543994 | Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcer… | Phase1 | Ulcerative Colitis | Terminated | 2020-11-10 | 2023-11-15 | ClinicalTrials.gov |
| NCT04548583 | Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn… | Phase1 | Crohn Colitis | Terminated | 2020-11-04 | 2023-11-15 | ClinicalTrials.gov |
| NCT04371393 | MSCs in COVID-19 ARDS | Phase3 | Mesenchymal Stromal Cells | Terminated | 2020-04-30 | 2022-01-02 | ClinicalTrials.gov |
| NCT02652130 | Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who … | Phase3 | Grade B Acute Graft Versus Host Disease | Completed | 2015-10-28 | 2018-06-15 | ClinicalTrials.gov |
| NCT02336230 | A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal … | Phase3 | Grade B aGVHD | Completed | 2015-06-04 | 2018-04-09 | ClinicalTrials.gov |
| NCT02412735 | Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hy… | Phase3 | Degenerative Disc Disease | Completed | 2015-03-06 | 2021-06-15 | ClinicalTrials.gov |
| NCT02032004 | Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L… | Phase3 | Chronic Heart Failure | Completed | 2014-03-03 | 2020-01-30 | ClinicalTrials.gov |
| NCT01854567 | P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation i… | Phase3 | Acute Myelogenous Leukemia | Completed | 2013-08-01 | 2017-05-05 | ClinicalTrials.gov |
| NCT01843387 | Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy | Phase1 | Diabetic Nephropathy | Completed | 2013-07-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01851070 | A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With R… | Phase2 | Rheumatoid Arthritis | Completed | 2013-07-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT01576328 | Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes | Phase1 | Type 2 Diabetes | Completed | 2012-04-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01290367 | Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in … | Phase2 | Degenerative Disc Disease | Completed | 2011-08-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01233960 | Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Di… | Phase3 | Crohn's Disease | Completed | 2010-11-29 | 2014-09-15 | ClinicalTrials.gov |
| NCT01106417 | Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterio… | Phase1 | Cervical Degenerative Disc Disease | Completed | 2010-06-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01097486 | Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-L… | Phase2 | Cervical Degenerative Disc Disease | Completed | 2010-06-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00996073 | Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar I… | Phase2 | Degenerative Disc Disease | Completed | 2009-09-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00877903 | Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocar… | Phase2 | Myocardial Infarction | Completed | 2009-03-30 | 2016-03-14 | ClinicalTrials.gov |
| NCT01088191 | Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cr… | Phase1 | Anterior Cruciate Ligament Injury | Completed | 2009-03-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00810212 | Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumba… | Phase1 | Degenerative Disc Disease | Withdrawn | 2008-11-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00721045 | A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transe… | Phase2 | Heart Failure | Completed | 2008-08-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00690066 | PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Typ… | Phase2 | Type 1 Diabetes Mellitus | Completed | 2008-06-11 | 2011-12-19 | ClinicalTrials.gov |
| NCT00562497 | Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids … | Phase3 | Graft Versus Host Disease | Completed | 2008-01-31 | 2010-05-20 | ClinicalTrials.gov |
| NCT00549913 | Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requ… | Phase1 | Degenerative Disc Disease | Completed | 2007-10-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT00482092 | Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderat… | Phase3 | Crohn's Disease | Completed | 2007-09-17 | 2014-09-15 | ClinicalTrials.gov |
| NCT00366145 | Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refr… | Phase3 | Graft Versus Host Disease | Completed | 2006-08-17 | 2009-05-28 | ClinicalTrials.gov |
| NCT00294112 | Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-seve… | Phase2 | Crohn's Disease | Completed | 2006-03-13 | 2006-07-21 | ClinicalTrials.gov |
| NCT00284986 | Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute … | Phase2 | Graft Versus Host Disease | Completed | 2005-11-18 | 2007-02-08 | ClinicalTrials.gov |
| NCT00225095 | A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Followi… | Phase1 | Recovery Following Partial Medial Meniscectomy | Completed | 2005-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00136903 | Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute … | Phase2 | Graft Vs Host Disease | Completed | 2005-04-27 | 2008-07-14 | ClinicalTrials.gov |
| NCT00114452 | Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial In… | Phase1 | Myocardial Infarction | Completed | 2005-03-22 | 2008-04-24 | ClinicalTrials.gov |
Total clinical trials: 36
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Placebo | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Remestemcel-L-rknd | Other | Phase PHASE3 | GVHD - Graft-Versus-Host Disease | NOT_YET_RECRUITING | NCT07568535 |
| Mesenchymal Precursor Cells (MPCs) | Other | Phase PHASE1 | Diabetic Nephropathy | COMPLETED | NCT01843387 |
| Hyaluronan | Other | Phase PHASE1 | Anterior Cruciate Ligament Injury | COMPLETED | NCT01088191 |
| MSB-CAR001 Combined With Hyaluronan | Other | Phase PHASE1 | Anterior Cruciate Ligament Injury | COMPLETED | NCT01088191 |
| Allograft | Other | Phase PHASE2 | Cervical Degenerative Disc Disease | COMPLETED | NCT01097486 |
| NeoFuse | Other | Phase PHASE2 | Cervical Degenerative Disc Disease | COMPLETED | NCT01097486 |
| PROCHYMAL (remestemcel-L) | Other | Preclinical | Crohn's Disease | NO_LONGER_AVAILABLE | NCT01510431 |
| Mesenchymal Precursor Cells (MPCs) | Other | Phase PHASE1 | Type 2 Diabetes | COMPLETED | NCT01576328 |
| Infusion of two unexpanded cord blood units. | Other | Phase PHASE3 | Acute Myelogenous Leukemia | COMPLETED | NCT01854567 |
| Infusion of one MPC expanded cord unit and one unexpanded cord unit | Other | Phase PHASE3 | Acute Myelogenous Leukemia | COMPLETED | NCT01854567 |
| Normal Saline | Other | Phase PHASE2 | Rheumatoid Arthritis | COMPLETED | NCT01851070 |
| Allogeneic Mesenchymal Precursor Cells | Other | Phase PHASE2 | Rheumatoid Arthritis | COMPLETED | NCT01851070 |
| Single injection of hyaluronic acid | Other | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT01290367 |
| Single injection of saline solution | Other | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT01290367 |
| Single Dose MPCs Injection | Other | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT01290367 |
| MasterGraft Granules | Other | Phase PHASE1 | Cervical Degenerative Disc Disease | COMPLETED | NCT01106417 |
| NeoFuse | Other | Phase PHASE1 | Cervical Degenerative Disc Disease | COMPLETED | NCT01106417 |
| Lumbar Interbody Fusion with NeoFuse | Other | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT00996073 |
| Lumbar Interbody Fusion with Autograft | Other | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT00996073 |
| Remestemcel-L | Other | Preclinical | Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19 | NO_LONGER_AVAILABLE | NCT04366830 |
| Remestemcel-L | Other | Preclinical | Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19 | NO_LONGER_AVAILABLE | NCT04366830 |
| Hyaluronan | Other | Phase PHASE1 | Recovery Following Partial Medial Meniscectomy | COMPLETED | NCT00225095 |
| Mesenchymal Stem Cells | Other | Phase PHASE1 | Recovery Following Partial Medial Meniscectomy | COMPLETED | NCT00225095 |
| Hyaluronan | Other | Phase PHASE1 | Recovery Following Partial Medial Meniscectomy | COMPLETED | NCT00225095 |
| Mesenchymal Stem Cells | Other | Phase PHASE1 | Recovery Following Partial Medial Meniscectomy | COMPLETED | NCT00225095 |
| Remestemcel-L | Other | Phase PHASE3 | Grade B Acute Graft Versus Host Disease | COMPLETED | NCT02652130 |
| remestemcel-L | Other | Phase PHASE3 | Grade B aGVHD | COMPLETED | NCT02336230 |
| Placebo | Other | Phase PHASE3 | Mesenchymal Stromal Cells | TERMINATED | NCT04371393 |
| Remestemcel-L | Other | Phase PHASE3 | Mesenchymal Stromal Cells | TERMINATED | NCT04371393 |
| Placebo | Other | Phase PHASE3 | Degenerative Disc Disease | COMPLETED | NCT02412735 |
| Rexlemestrocel-L + HA Mixture | Other | Phase PHASE3 | Degenerative Disc Disease | COMPLETED | NCT02412735 |
| Rexlemestrocel-L | Other | Phase PHASE3 | Degenerative Disc Disease | COMPLETED | NCT02412735 |
| Placebo | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Remestemcel-L | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Diphenhydramine | Other | Preclinical | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | NO_LONGER_AVAILABLE | NCT04456439 |
| Hydrocortisone | Other | Preclinical | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | NO_LONGER_AVAILABLE | NCT04456439 |
| Remestemcel-L | Other | Preclinical | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | NO_LONGER_AVAILABLE | NCT04456439 |
| Diphenhydramine | Other | Preclinical | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | NO_LONGER_AVAILABLE | NCT04456439 |
| Hydrocortisone | Other | Preclinical | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | NO_LONGER_AVAILABLE | NCT04456439 |
| Remestemcel-L | Other | Preclinical | Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) | NO_LONGER_AVAILABLE | NCT04456439 |
| Saline | Other | Phase PHASE3 | Degenerative Disc Disease | RECRUITING | NCT06325566 |
| Rexlemestrocel-L + HA mixture | Other | Phase PHASE3 | Degenerative Disc Disease | RECRUITING | NCT06325566 |
| Prochymal® | Other | Phase PHASE3 | Crohn's Disease | COMPLETED | NCT01233960 |
| Sham Comparator | Other | Phase PHASE3 | Chronic Heart Failure | COMPLETED | NCT02032004 |
| Rexlemestrocel-L | Other | Phase PHASE3 | Chronic Heart Failure | COMPLETED | NCT02032004 |
| Placebo | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Remestemcel-L | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Placebo | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Remestemcel-L | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Placebo | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Remestemcel-L | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Placebo | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Remestemcel-L | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Placebo | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Remestemcel-L | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Placebo | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Remestemcel-L | Other | Phase PHASE1 | Crohn Colitis | TERMINATED | NCT04548583 |
| Placebo | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Remestemcel-L | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Placebo | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Remestemcel-L | Other | Phase PHASE1 | Ulcerative Colitis | TERMINATED | NCT04543994 |
| Saline | DRUG | Phase PHASE3 | Degenerative Disc Disease | RECRUITING | NCT06325566 |
| Rexlemestrocel-L + HA mixture | DRUG | Phase PHASE3 | Degenerative Disc Disease | RECRUITING | NCT06325566 |
| Placebo | DRUG | Phase PHASE3 | Degenerative Disc Disease | COMPLETED | NCT02412735 |
| Rexlemestrocel-L + HA Mixture | DRUG | Phase PHASE3 | Degenerative Disc Disease | COMPLETED | NCT02412735 |
| Rexlemestrocel-L | DRUG | Phase PHASE3 | Degenerative Disc Disease | COMPLETED | NCT02412735 |
| Infusion of two unexpanded cord blood units. | BIOLOGICAL | Phase PHASE3 | Acute Myelogenous Leukemia | COMPLETED | NCT01854567 |
| Infusion of one MPC expanded cord unit and one unexpanded cord unit | BIOLOGICAL | Phase PHASE3 | Acute Myelogenous Leukemia | COMPLETED | NCT01854567 |
| Normal Saline | DRUG | Phase PHASE2 | Rheumatoid Arthritis | COMPLETED | NCT01851070 |
| Allogeneic Mesenchymal Precursor Cells | DRUG | Phase PHASE2 | Rheumatoid Arthritis | COMPLETED | NCT01851070 |
| Single injection of hyaluronic acid | PROCEDURE | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT01290367 |
| Single injection of saline solution | PROCEDURE | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT01290367 |
| Single Dose MPCs Injection | BIOLOGICAL | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT01290367 |
| Lumbar Interbody Fusion with NeoFuse | BIOLOGICAL | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT00996073 |
| Lumbar Interbody Fusion with Autograft | BIOLOGICAL | Phase PHASE2 | Degenerative Disc Disease | COMPLETED | NCT00996073 |
| MasterGraft Granules | DEVICE | Phase PHASE1 | Cervical Degenerative Disc Disease | COMPLETED | NCT01106417 |
| Allograft | PROCEDURE | Phase PHASE2 | Cervical Degenerative Disc Disease | COMPLETED | NCT01097486 |
| Hyaluronan | DRUG | Phase PHASE1 | Anterior Cruciate Ligament Injury | COMPLETED | NCT01088191 |
| MSB-CAR001 Combined With Hyaluronan | BIOLOGICAL | Phase PHASE1 | Anterior Cruciate Ligament Injury | COMPLETED | NCT01088191 |
| PLF with NeoFuse | BIOLOGICAL | Phase PHASE1 | Degenerative Disc Disease | WITHDRAWN | NCT00810212 |
| PLF with autograft | PROCEDURE | Phase PHASE1 | Degenerative Disc Disease | WITHDRAWN | NCT00810212 |
| standard-of-care treatment with mock mapping and injection procedures. | PROCEDURE | Phase PHASE2 | Heart Failure | COMPLETED | NCT00721045 |
| Mesenchymal Precursor Cells (MPCs) | BIOLOGICAL | Phase PHASE1 | Diabetic Nephropathy | COMPLETED | NCT01843387 |
| posterolateral spinal fusion with instrumentation | PROCEDURE | Phase PHASE1 | Degenerative Disc Disease | COMPLETED | NCT00549913 |
| NeoFuse | BIOLOGICAL | Phase PHASE1 | Cervical Degenerative Disc Disease | COMPLETED | NCT01106417 |
Total products: 114